基于列线图的术前评分预测单侧原发性醛固酮增多症临床结局
该研究在亚洲队列中开发并验证了基于列线图的术前评分(NBPS),用于预测单侧原发性醛固酮增多症(UPA)患者肾上腺切除术后高血压缓解情况。NBPS纳入了性别、高血压病程、醛固酮与肾素比值和靶器官损害,在亚洲队列中预测高血压缓解的AUC为0.853(0.786-0.905),优于ARS和PASO评分;在白人验证队列中AUC为0.830(0.764-0.884),优于ARS但与PASO评分无显著差异。
要点
- NBPS可用于预测UPA患者术后高血压缓解,尤其在亚洲人群中表现更优。
- NBPS预测性能优于ARS评分,在亚洲队列中也优于PASO评分。
- NBPS纳入了性别、高血压病程、醛固酮与肾素比值和靶器官损害四个预测因子。
核心结论
- NBPS有助于预测UPA患者肾上腺切除术后的临床结局,尤其在亚洲人群中。
研究设计与样本
- 在亚洲队列中开发NBPS,并在白人队列中进行验证。
- 训练队列150例,验证队列165例,均为UPA行肾上腺切除术后生化完全成功的患者。
主要发现
- NBPS预测训练队列高血压缓解的AUC为0.853(0.786-0.905),优于ARS(0.745 [0.667-0.812],P = .019)和PASO评分(0.747 [0.670-0.815],P = .012)。
- 验证队列中NBPS的AUC为0.830(0.764-0.884),高于ARS(0.745 [95% CI, 0.672-0.810],P = .045),但与PASO评分(0.825 [95% CI, 0.758-0.880],P = .911)无显著差异。
关键数值与推荐
- NBPS纳入了性别、高血压病程、醛固酮与肾素比值和靶器官损害。
- NBPS在亚洲和白人队列中均显示良好的C指数和校准曲线。
临床怎么用
- 对于UPA患者,术前可使用NBPS评估肾上腺切除术后高血压缓解的可能性,辅助临床决策。
局限性
- 研究未报告NBPS在非亚洲人群中的进一步验证细节。
- 样本量有限,需更大规模研究确认其普遍适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: More than half of patients diagnosed with unilateral primary aldosteronism (UPA) suffer from persisting hypertension after unilateral adrenalectomy. OBJECTIVE: The objective of this work is to develop and validate a nomogram-based preoperative score (NBPS) to predict clinical outcomes after unilateral adrenalectomy for UPA. DESIGN AND SETTING: The NBPS was developed in an Asian cohort by incorporating predictors independently associated with remission of hypertension after unilateral adrenalectomy for UPA and validated in a Caucasian cohort. PARTICIPANTS: Participants comprised patients with UPA achieving complete biochemical success after unilateral adrenalectomy. MAIN OUTCOME MEASURE: Measurements included the predictive performance of the NBPS compared with 2 previously developed outcome prediction scores: aldosteronoma resolution score (ARS) and primary aldosteronism surgical outcome (PASO) score. RESULTS: Ninety-seven of 150 (64.7%) patients achieved complete clinical success after unilateral adrenalectomy in the training cohort and 57 out of 165 (34.5%) in the validation cohort. A nomogram was established incorporating sex, duration of hypertension, aldosterone-to-renin ratio, and target organ damage. The nomogram showed good C indices and calibration curves both in Asian and Caucasian cohorts. The area under the receiver operating characteristic curve (AUC) of the NBPS for predicting hypertension remission in the training cohort was 0.853 (0.786-0.905), which was superior to the ARS (0.745 [0.667-0.812], P = .019) and PASO score (0.747 [0.670-0.815], P = .012). The AUC of the NBPS in the validation cohort was 0.830 (0.764-0.884), which was higher than the ARS (0.745 [95% CI, 0.672-0.810], P = .045), but not significantly different from the PASO score (0.825 [95% CI, 0.758-0.880], P = .911). CONCLUSION: The NBPS is useful in predicting clinical outcome for UPA patients, especially in the Asian population.
引用
- Yang Y, Williams TA, Song Y, et al. Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism. J Clin Endocrinol Metab. 2020. PMID: 32898224. doi:10.1210/clinem/dgaa634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。